Stephanie G. Craig

ORCID: 0000-0002-5476-751X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer Immunotherapy and Biomarkers
  • Radiomics and Machine Learning in Medical Imaging
  • Colorectal Cancer Treatments and Studies
  • AI in cancer detection
  • Genetic factors in colorectal cancer
  • Molecular Biology Techniques and Applications
  • Esophageal Cancer Research and Treatment
  • Cancer Genomics and Diagnostics
  • Exercise and Physiological Responses
  • Cell Image Analysis Techniques
  • Colorectal and Anal Carcinomas
  • Cancer Research and Treatments
  • RNA modifications and cancer
  • Health Promotion and Cardiovascular Prevention
  • Cancer Treatment and Pharmacology
  • Oral Health Pathology and Treatment
  • Head and Neck Cancer Studies
  • Acute Myeloid Leukemia Research
  • RNA Research and Splicing
  • Cancer-related Molecular Pathways
  • Genomics and Chromatin Dynamics
  • Immunotherapy and Immune Responses
  • Epigenetics and DNA Methylation
  • Dietary Effects on Health
  • Gastric Cancer Management and Outcomes

Queen's University Belfast
2016-2025

University of Guelph
2023-2024

NOSM University
2024

Belfast Health and Social Care Trust
2024

York University
2023

Williams (United States)
2023

Dalhousie University
2022

Binghamton University
2022

Hospital for Sick Children
2022

Multiplex immunofluorescence is a powerful tool for the simultaneous detection of tissue-based biomarkers, revolutionising traditional immunohistochemistry. The Opal methodology allows up to eight biomarkers be measured concomitantly without cross-reactivity, permitting identification different cell populations within tumour microenvironment. In this study, we aimed validate multiplex workflow in two complementary panels and evaluate immune microenvironment colorectal cancer (CRC)...

10.1002/1878-0261.12764 article EN cc-by Molecular Oncology 2020-07-16

TNM8 staging for oropharyngeal squamous cell carcinomas (OPSCC) surrogates p16 immunohistochemistry HPV testing. Patients with p16+ OPSCC may lack aetiology. Here, we evaluate the suitability of guiding prognosis in such patients.

10.1038/s41416-019-0414-9 article EN cc-by British Journal of Cancer 2019-03-20

Aims Establishing the mismatch repair (MMR) status of colorectal cancers is important to enable detection underlying Lynch syndrome and inform prognosis therapy. Current testing typically involves either polymerase chain reaction (PCR)‐based microsatellite instability (MSI) or MMR protein immunohistochemistry (IHC). The aim this study was compare these two approaches in a large, population‐based cohort stage 2 3 colon cancer cases Northern Ireland. Methods results used Promega pentaplex...

10.1111/his.14233 article EN cc-by Histopathology 2020-08-13

Abstract Oral epithelial dysplasia (OED) is a premalignant histopathological diagnosis given to lesions of the oral cavity. Its grading suffers from significant inter-/intra-observer variability, and does not reliably predict malignancy progression, potentially leading suboptimal treatment decisions. To address this, we developed an artificial intelligence (AI) algorithm, that assigns Malignant Transformation (OMT) risk score based on Haematoxylin Eosin (H&E) stained whole slide images...

10.1038/s41698-024-00624-8 article EN cc-by npj Precision Oncology 2024-06-28

Output from biomarker studies involving immunohistochemistry applied to tissue microarrays (TMA) is limited by the lack of an efficient and reproducible scoring methodology. In this study, we examine functionality reproducibility using new, open-source, digital image analysis software, QuPath.

10.1111/his.13516 article EN Histopathology 2018-03-25

Abstract Background Immunohistochemical quantification of the immune response is prognostic for colorectal cancer (CRC). Here, we evaluate suitability alternative classifiers on prognosis and assess whether they relate to biological features amenable targeted therapy. Methods Overall survival by (CD3, CD4, CD8, CD20 FOXP3) immune-checkpoint (ICOS, IDO-1 PD-L1) biomarkers in independent CRC cohorts was evaluated. Matched mutational transcriptomic data were interrogated identify associated...

10.1038/s41416-020-0985-5 article EN cc-by British Journal of Cancer 2020-07-19

Patient suitability to anti-programmed death ligand 1 (PD-L1) immune checkpoint inhibition is key the treatment of NSCLC. We present, applied PD-L1 testing: a comprehensive cross-validation two immunohistochemistry (IHC) clones; our descriptive experience in diagnostic reflex testing; concordance IHC situ RNA (RNA-ISH); and application digital pathology.

10.1016/j.jtho.2018.09.025 article EN cc-by Journal of Thoracic Oncology 2018-10-06

// Victoria Bingham 2 , Leanne McIlreavey Christine Greene 1,3 Edwina O’Doherty Rebecca Clarke Stephanie Craig Manuel Salto-Tellez Stephen McQuaid 1,2,3 Claire Lewis 1,2 and Jacqueline James 1 Northern Ireland Biobank, Centre for Cancer Research Cell Biology, Queen’s University, Belfast, UK Molecular Pathology Programme, 3 Tissue Pathology, Belfast Health Social Care Trust, City Hospital, Correspondence to: McQuaid, email: Keywords : mRNA; FFPE; in situ hybridization; Integrity;...

10.18632/oncotarget.21851 article EN Oncotarget 2017-10-16

// Conor A. Bradley 1, * , Philip D. Dunne Victoria Bingham 1 Stephen McQuaid 2 Hajrah Khawaja Stephanie Craig Jackie James Wendy L. Moore Darragh G. McArt Mark Lawler Sonali Dasgupta Patrick Johnston Sandra Van Schaeybroeck Drug Resistance Group, Centre for Cancer Research and Cell Biology, School of Medicine, Dentistry Biomedical Science, Queen's University Belfast, UK Tissue Pathology, Belfast Health Social Care Trust, City Hospital, Joint first authors Correspondence to: Schaeybroeck,...

10.18632/oncotarget.12933 article EN Oncotarget 2016-10-26

Targeting of the programmed cell death protein (PD-1)/programmed death-ligand 1 (PD-L1) axis with checkpoint inhibitors has changed clinical practice in non-small lung cancer (NSCLC). However, assessment remains complex and ambiguous. We aim to assess whether digital image analysis (DIA) multiplex immunofluorescence can improve accuracy PD-L1 diagnostic testing. A cohort routine NSCLC patients reflex tested for (SP263) immunohistochemistry (IHC), was assessed using DIA. Samples varying...

10.3390/cancers12051114 article EN Cancers 2020-04-29

STING signaling in cancer is a crucial component of response to immunotherapy and other anti-cancer treatments. Currently, there no robust method measuring activation cancer. Here, we describe an immunohistochemistry-based assay with digital pathology assessment tumor cells. Using this novel approach estrogen receptor-positive (ER+) ER- breast cancer, identify perinuclear-localized expression (pnSTING) ER+ cases as independent predictor good prognosis, associated immune cell infiltration...

10.1038/s41523-021-00283-z article EN cc-by npj Breast Cancer 2021-06-25

Biomarkers identify patient response to therapy. The potential immune-checkpoint biomarker, Inducible T-cell COStimulator (ICOS), expressed on regulating activation and involved in adaptive immune responses, is of great interest. We have previously shown that open-source software for digital pathology image analysis can be used detect quantify ICOS using cell detection algorithms based traditional processing techniques. Currently, artificial intelligence (AI) deep learning methods...

10.3390/cancers13153825 article EN Cancers 2021-07-29
Ruoran Li Molly Deutsch-Feldman Tamasin Adams Michelle Law Biak Chinpar and 95 more Erika Pitcher Marci Drees Alfonso C. Hernández-Romieu Thomas D. Filardo Tracina Cropper Angelica Martinez Wendy Wilson Sandy Althomsons Sapna Bamrah Morris Jonathan M. Wortham Isaac Benowitz Noah G. Schwartz Kelly White Maryam B. Haddad Janet Glowicz Kristen Herrick Brancato Renuka Khurana Elizabeth Kim Cherie Stafford Evan Timme Ruoran Li Kristin Edler Jennifer Flood C Kin Lam Scott A. Nabity Tambi Shaw Robert Belknap Juli Bettridge Caitlin M. Brown Christopher A. Czaja Peter B. Dupree Michelle Haas Kristen E. Marshall Ann M. Scarpita Kelsey E. Star Carol A Briody Marci Drees Chad Duffalo Mark S. Eskander Emily Hanlin Rick Hong Kenneth Lingenfelter Tabe Mase Heather Pelkey Malikah Taylor Duane A Ashe David Ashkin Argentina R Charles Melanie A Coleman Jalysa N Erskine Lori A Johnston Christopher Prestel Thomas Privett LaTweika A T Salmon Marcia Yolman E. L. Anderson Jeanne Negley Susan M. Ray Benjamin Yarn Catherine A Counard Elaine Darnall Shelly Reeter Lisa A Tossi Tamasin Adams Haley Beeman Amy L Bennitt Jill Brock Rachel Cathey Biak Chinpar Roxane Collins Stephanie G. Craig Amy Fohl Lauren Gunderson Diedre Hamilton Alicia Hill Carma Jo Johnson Mary Kinser Christy Kitt Scovia M Kiwanuka Sarah P Koch Debra A Krafft Nikki LaTourrette Michelle Law Dixie Meyer Sandy Miller Sandra Morse Christina K. Nolan Erika Pitcher Carrie Ramey Teresa L. Reed Catherine Sartino Kimberly Schneider Rhomonda Scifres Nancy B. Wagner Mary Kate Weber

Abstract A nationwide tuberculosis outbreak linked to a viable bone allograft product contaminated with Mycobacterium was identified in June 2021. Our subsequent investigation 73 healthcare personnel new latent infection following exposure the product, recipients, surgical instruments, or medical waste.

10.1093/cid/ciad029 article EN public-domain Clinical Infectious Diseases 2023-01-20

Abstract Purpose To investigate the association between cigarette smoking, alcohol consumption, and esophageal adenocarcinoma survival, including stratified analysis by selected prognostic biomarkers. Methods A population-representative sample of 130 patients (n = 130) treated at Northern Ireland Cancer Centre 2004 2012. Cox proportional hazards models were applied to evaluate associations smoking status, intake, survival. Secondary analyses investigated these across categories p53, HER2,...

10.1007/s10552-019-01247-2 article EN cc-by Cancer Causes & Control 2019-11-30

Abstract Background Limited studies examine the immune landscape in Esophageal Adenocarcinoma (EAC). We aim to identify novel associations, which may inform immunotherapy treatment stratification. Methods Three hundred twenty-nine EAC cases were available Tissue Microarrays (TMA) format. A discovery cohort of 166 stained immunohistochemically for range adaptive (CD3, CD4, CD8 and CD45RO) checkpoint biomarkers (ICOS, IDO-1, PD-L1, PD-1). validation 163 was also accessed. digital pathology...

10.1186/s12885-020-06987-y article EN cc-by BMC Cancer 2020-06-01

Abstract Purpose: The DNA damage immune response (DDIR) assay was developed in breast cancer based on biology associated with deficiencies homologous recombination and Fanconi anemia pathways. A positive DDIR call identifies patients likely to respond platinum-based chemotherapies esophageal cancers. In colorectal cancer, there is currently no biomarker predict oxaliplatin. We tested the ability of oxaliplatin-based chemotherapy characterized DDIR-positive cancer. Experimental Design:...

10.1158/1078-0432.ccr-20-3237 article EN Clinical Cancer Research 2020-10-07

Abstract Purpose: To investigate the regulation of epithelial-to-mesenchymal transition (EMT) in head and neck squamous cell carcinoma (HNSCC) its importance tumor invasion. Experimental Design: We use a three-dimensional invasive organotypic raft culture model human foreskin keratinocytes expressing E6/E7 genes papilloma virus-16, coupled with bioinformatic IHC analysis patient samples to role played by EMT invasion identify effectors upstream regulatory pathways. Results: SNAI2 (Slug) as...

10.1158/1078-0432.ccr-17-3775 article EN Clinical Cancer Research 2018-05-08

Abstract Background The cohesin complex plays a major role in folding the human genome into 3D structural domains. Mutations members of are known early drivers myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML), with STAG2 most frequently mutated member. Methods Here we use functional genomics (RNA-seq, ChIP-seq HiChIP) to investigate impact chronic loss on three-dimensional structure transcriptional programming clinically relevant model loss. Results led smaller loop domains...

10.1186/s12967-020-02500-y article EN cc-by Journal of Translational Medicine 2020-09-03

Identifying robust predictive biomarkers to stratify colorectal cancer (CRC) patients based on their response immune-checkpoint therapy is an area of unmet clinical need. Our evolutionary algorithm Atlas Correlation Explorer (ACE) represents a novel approach for mining The Cancer Genome (TCGA) data clinically relevant associations. We deployed ACE identify candidate in CRC. interrogated the colon adenocarcinoma (COAD) gene expression across nine immune-checkpoints (PDL1, PDCD1, CTLA4, LAG3,...

10.1093/nargab/lqab016 article EN cc-by NAR Genomics and Bioinformatics 2021-04-09

Abstract Background Oral epithelial dysplasia (OED) is the precursor to oral squamous cell carcinoma which amongst top ten cancers worldwide. Prognostic significance of conventional histological features in OED not well established. Many additional abnormalities are seen OED, but insufficiently investigated, and have been correlated clinical outcomes. Methods A digital quantitative analysis cellularity, nuclear geometry, cytoplasm staining intensity architecture/thickness conducted on 75...

10.1038/s41416-023-02438-0 article EN cc-by British Journal of Cancer 2023-09-27
Coming Soon ...